Ray Gerald L & Associates LTD: 13F Holdings & AI Insights

CIK: 0000837286

Long-term holder

Total reported value

—

Reporting period: 2018-09-30 · Number of holdings: 1

RAY GERALD L & ASSOCIATES LTD disclosed 1 holdings in its latest 13F filing for the period ending 2018-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.

Browse other institutions starting with "R"

Personality snowflake

Concentration: 0
Portfolio Stability: 0
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 2
Sizing Uniformity: —

Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.

Recent moves

Unchanged 000000000
　$0.0

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	✓	Ikena Oncology INC	Stock-Other	—	—	—

Portfolio Performance

Not enough priced holdings yet to compute performance

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2018-09-30	1	—	0
2018-06-30	1	—	100
2017-09-30	354	$802.1M	13	1LUV 2CELG 3REGN Top holdings2017-09-30 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.META 8.V 9.HON 10.BAC
2017-06-30	350	$775.5M	12	1LUV 2CELG 3REGN Top holdings2017-06-30 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.META 8.V 9.PEP 10.JNJ
2017-03-31	338	$730.5M	11	1LUV 2CELG 3AAPL Top holdings2017-03-31 1.LUV 2.CELG 3.AAPL 4.REGN 5.AMGN 6.JPM 7.V 8.META 9.PEP 10.AEP
2016-12-31	350	$689.8M	14	1LUV 2CELG 3REGN Top holdings2016-12-31 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.AEP 8.V 9.PEP 10.BAC
2016-09-30	358	$666.8M	17	1LUV 2CELG 3REGN Top holdings2016-09-30 1.LUV 2.CELG 3.REGN 4.AMGN 5.AAPL 6.JPM 7.AEP 8.V 9.PEP 10.JNJ
2016-06-30	464	$625.7M	11	1LUV 2CELG 3REGN Top holdings2016-06-30 1.LUV 2.CELG 3.REGN 4.AMGN 5.AAPL 6.JPM 7.AEP 8.JNJ 9.PEP 10.CL
2016-03-31	455	$617.1M	13	1LUV 2CELG 3REGN Top holdings2016-03-31 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.AEP 7.JPM 8.PEP 9.V 10.CL
2015-12-31	463	$633.0M	13	1LUV 2REGN 3CELG Top holdings2015-12-31 1.LUV 2.REGN 3.CELG 4.AMGN 5.AAPL 6.JPM 7.AEP 8.V 9.PEP 10.DIS
2015-09-30	453	$599.7M	15	1LUV 2REGN 3CELG Top holdings2015-09-30 1.LUV 2.REGN 3.CELG 4.AAPL 5.AMGN 6.JPM 7.UAA 8.PEP 9.AEP 10.DIS
2015-06-30	475	$657.2M	9	1REGN 2LUV 3CELG Top holdings2015-06-30 1.REGN 2.LUV 3.CELG 4.AAPL 5.AMGN 6.JPM 7.AEP 8.PEP 9.CL 10.UAA
2015-03-31	474	$664.6M	10	1LUV 2CELG 3REGN Top holdings2015-03-31 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.CL 8.AEP 9.PEP 10.UAA
2014-12-31	462	$650.3M	14	1LUV 2CELG 3REGN Top holdings2014-12-31 1.LUV 2.CELG 3.REGN 4.AMGN 5.AAPL 6.JPM 7.CL 8.AEP 9.PEP 10.JNJ
2014-09-30	464	$614.5M	10	1LUV 2CELG 3REGN Top holdings2014-09-30 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.AEP 8.CL 9.JNJ 10.PEP
2014-06-30	465	$586.7M	10	1LUV 2CELG 3REGN Top holdings2014-06-30 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.AEP 8.CL 9.SNDK 10.JNJ
2014-03-31	442	$551.9M	9	1LUV 2REGN 3CELG Top holdings2014-03-31 1.LUV 2.REGN 3.CELG 4.AMGN 5.AAPL 6.JPM 7.AEP 8.CL 9.JNJ 10.PEP
2013-12-31	439	$530.7M	13	1CELG 2REGN 3LUV Top holdings2013-12-31 1.CELG 2.REGN 3.LUV 4.AMGN 5.AAPL 6.JPM 7.AEP 8.CL 9.PEP 10.JNJ
2013-09-30	428	$483.5M	11	1REGN 2CELG 3AMGN Top holdings2013-09-30 1.REGN 2.CELG 3.AMGN 4.LUV 5.AAPL 6.JPM 7.AEP 8.CL 9.PEP 10.JNJ
2013-06-30	412	$446.6M	0	1REGN 2CELG 3AMGN Top holdings2013-06-30 1.REGN 2.CELG 3.AMGN 4.LUV 5.JPM 6.AAPL 7.AEP 8.CL 9.PEP 10.JNJ

Holding changes this quarter

Position changes disclosed by Ray Gerald L & Associates LTD for the quarter ending 2018-09-30, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	✓	Ikena Oncology INC	—	—	Unchanged

Filing History

Period	Filed	Type	EDGAR
2018-09-30	2018-10-31	13F-HR	View on EDGAR
2018-06-30	2018-07-31	13F-HR	View on EDGAR
2017-09-30	2017-10-31	13F-HR	View on EDGAR
2017-06-30	2017-08-08	13F-HR	View on EDGAR
2017-03-31	2017-05-03	13F-HR	View on EDGAR
2016-12-31	2017-02-07	13F-HR	View on EDGAR
2016-09-30	2016-11-09	13F-HR	View on EDGAR
2016-06-30	2016-08-15	13F-HR	View on EDGAR
2016-03-31	2016-05-05	13F-HR	View on EDGAR
2015-12-31	2016-02-08	13F-HR	View on EDGAR
2015-09-30	2015-11-10	13F-HR	View on EDGAR
2015-06-30	2015-08-03	13F-HR	View on EDGAR
2015-03-31	2015-05-06	13F-HR	View on EDGAR
2014-12-31	2015-02-10	13F-HR	View on EDGAR
2014-09-30	2014-11-03	13F-HR	View on EDGAR
2014-06-30	2014-08-04	13F-HR	View on EDGAR
2014-03-31	2014-05-07	13F-HR	View on EDGAR
2013-12-31	2014-02-05	13F-HR	View on EDGAR
2013-09-30	2013-11-05	13F-HR	View on EDGAR
2013-06-30	2013-08-01	13F-HR	View on EDGAR

FAQ

What is Ray Gerald L & Associates LTD and what type of investor is it?

Ray Gerald L & Associates LTD is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2018-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.

What are Ray Gerald L & Associates LTD's largest equity positions?

Based on the latest 13F filing, Ray Gerald L & Associates LTD's top holdings by market value are: 1. Ikena Oncology INC — $0.0

What changes did Ray Gerald L & Associates LTD make in its most recent portfolio filing?

No notable portfolio changes were recorded for Ray Gerald L & Associates LTD in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does Ray Gerald L & Associates LTD focus on?

Sector breakdown data is not yet available for Ray Gerald L & Associates LTD. Check back after the next 13F processing cycle.

Peer Institutions

Institutions with a similar AUM

Cowen And Company, LLC

CIK 0000048966

Total reported value

—

1 stks

2024-12-31

Stale — no recent filing

Concentration0.0

Portfolio Stability0.0

Sector conviction0.0

View detail

Kresge Foundation

CIK 0000056822

Total reported value

—

1 stks

2019-12-31

Stale — no recent filing

Concentration0.0

Portfolio Stability0.0

Sector conviction0.0

View detail

Resource America, INC.

CIK 0000083402

Total reported value

—

1 stks

2021-09-30

Stale — no recent filing

Concentration0.0

Portfolio Stability0.0

Sector conviction0.0

View detail

Ray Gerald L & Associates LTD: 13F Holdings & AI Insights

CIK: 0000837286

Long-term holder

Total reported value

—

Reporting period: 2018-09-30 · Number of holdings: 1

RAY GERALD L & ASSOCIATES LTD disclosed 1 holdings in its latest 13F filing for the period ending 2018-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.

Browse other institutions starting with "R"

Personality snowflake

Concentration: 0
Portfolio Stability: 0
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 2
Sizing Uniformity: —

Recent moves

Unchanged 000000000
　$0.0

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	✓	Ikena Oncology INC	Stock-Other	—	—	—

Portfolio Performance

Not enough priced holdings yet to compute performance

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2018-09-30	1	—	0
2018-06-30	1	—	100
2017-09-30	354	$802.1M	13	1LUV 2CELG 3REGN Top holdings2017-09-30 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.META 8.V 9.HON 10.BAC
2017-06-30	350	$775.5M	12	1LUV 2CELG 3REGN Top holdings2017-06-30 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.META 8.V 9.PEP 10.JNJ
2017-03-31	338	$730.5M	11	1LUV 2CELG 3AAPL Top holdings2017-03-31 1.LUV 2.CELG 3.AAPL 4.REGN 5.AMGN 6.JPM 7.V 8.META 9.PEP 10.AEP
2016-12-31	350	$689.8M	14	1LUV 2CELG 3REGN Top holdings2016-12-31 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.AEP 8.V 9.PEP 10.BAC
2016-09-30	358	$666.8M	17	1LUV 2CELG 3REGN Top holdings2016-09-30 1.LUV 2.CELG 3.REGN 4.AMGN 5.AAPL 6.JPM 7.AEP 8.V 9.PEP 10.JNJ
2016-06-30	464	$625.7M	11	1LUV 2CELG 3REGN Top holdings2016-06-30 1.LUV 2.CELG 3.REGN 4.AMGN 5.AAPL 6.JPM 7.AEP 8.JNJ 9.PEP 10.CL
2016-03-31	455	$617.1M	13	1LUV 2CELG 3REGN Top holdings2016-03-31 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.AEP 7.JPM 8.PEP 9.V 10.CL
2015-12-31	463	$633.0M	13	1LUV 2REGN 3CELG Top holdings2015-12-31 1.LUV 2.REGN 3.CELG 4.AMGN 5.AAPL 6.JPM 7.AEP 8.V 9.PEP 10.DIS
2015-09-30	453	$599.7M	15	1LUV 2REGN 3CELG Top holdings2015-09-30 1.LUV 2.REGN 3.CELG 4.AAPL 5.AMGN 6.JPM 7.UAA 8.PEP 9.AEP 10.DIS
2015-06-30	475	$657.2M	9	1REGN 2LUV 3CELG Top holdings2015-06-30 1.REGN 2.LUV 3.CELG 4.AAPL 5.AMGN 6.JPM 7.AEP 8.PEP 9.CL 10.UAA
2015-03-31	474	$664.6M	10	1LUV 2CELG 3REGN Top holdings2015-03-31 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.CL 8.AEP 9.PEP 10.UAA
2014-12-31	462	$650.3M	14	1LUV 2CELG 3REGN Top holdings2014-12-31 1.LUV 2.CELG 3.REGN 4.AMGN 5.AAPL 6.JPM 7.CL 8.AEP 9.PEP 10.JNJ
2014-09-30	464	$614.5M	10	1LUV 2CELG 3REGN Top holdings2014-09-30 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.AEP 8.CL 9.JNJ 10.PEP
2014-06-30	465	$586.7M	10	1LUV 2CELG 3REGN Top holdings2014-06-30 1.LUV 2.CELG 3.REGN 4.AAPL 5.AMGN 6.JPM 7.AEP 8.CL 9.SNDK 10.JNJ
2014-03-31	442	$551.9M	9	1LUV 2REGN 3CELG Top holdings2014-03-31 1.LUV 2.REGN 3.CELG 4.AMGN 5.AAPL 6.JPM 7.AEP 8.CL 9.JNJ 10.PEP
2013-12-31	439	$530.7M	13	1CELG 2REGN 3LUV Top holdings2013-12-31 1.CELG 2.REGN 3.LUV 4.AMGN 5.AAPL 6.JPM 7.AEP 8.CL 9.PEP 10.JNJ
2013-09-30	428	$483.5M	11	1REGN 2CELG 3AMGN Top holdings2013-09-30 1.REGN 2.CELG 3.AMGN 4.LUV 5.AAPL 6.JPM 7.AEP 8.CL 9.PEP 10.JNJ
2013-06-30	412	$446.6M	0	1REGN 2CELG 3AMGN Top holdings2013-06-30 1.REGN 2.CELG 3.AMGN 4.LUV 5.JPM 6.AAPL 7.AEP 8.CL 9.PEP 10.JNJ

Holding changes this quarter

Position changes disclosed by Ray Gerald L & Associates LTD for the quarter ending 2018-09-30, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	✓	Ikena Oncology INC	—	—	Unchanged

Filing History

Period	Filed	Type	EDGAR
2018-09-30	2018-10-31	13F-HR	View on EDGAR
2018-06-30	2018-07-31	13F-HR	View on EDGAR
2017-09-30	2017-10-31	13F-HR	View on EDGAR
2017-06-30	2017-08-08	13F-HR	View on EDGAR
2017-03-31	2017-05-03	13F-HR	View on EDGAR
2016-12-31	2017-02-07	13F-HR	View on EDGAR
2016-09-30	2016-11-09	13F-HR	View on EDGAR
2016-06-30	2016-08-15	13F-HR	View on EDGAR
2016-03-31	2016-05-05	13F-HR	View on EDGAR
2015-12-31	2016-02-08	13F-HR	View on EDGAR
2015-09-30	2015-11-10	13F-HR	View on EDGAR
2015-06-30	2015-08-03	13F-HR	View on EDGAR
2015-03-31	2015-05-06	13F-HR	View on EDGAR
2014-12-31	2015-02-10	13F-HR	View on EDGAR
2014-09-30	2014-11-03	13F-HR	View on EDGAR
2014-06-30	2014-08-04	13F-HR	View on EDGAR
2014-03-31	2014-05-07	13F-HR	View on EDGAR
2013-12-31	2014-02-05	13F-HR	View on EDGAR
2013-09-30	2013-11-05	13F-HR	View on EDGAR
2013-06-30	2013-08-01	13F-HR	View on EDGAR

FAQ

What is Ray Gerald L & Associates LTD and what type of investor is it?

What are Ray Gerald L & Associates LTD's largest equity positions?

Based on the latest 13F filing, Ray Gerald L & Associates LTD's top holdings by market value are: 1. Ikena Oncology INC — $0.0

What changes did Ray Gerald L & Associates LTD make in its most recent portfolio filing?

No notable portfolio changes were recorded for Ray Gerald L & Associates LTD in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does Ray Gerald L & Associates LTD focus on?

Sector breakdown data is not yet available for Ray Gerald L & Associates LTD. Check back after the next 13F processing cycle.